Screener
Royalty Pharma RPRX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $728.46M+100% | $718.23M+20.5% | $827.15M+11.4% | $702.62M-0.1% | $363.98M-44.7% | ||
| —— | —— | —— | $226K— | —— | ||
| -$229.72M+26.4% | -$477.87M-195% | -$847.8M-67.7% | -$958.31M+19.7% | -$311.98M+65.1% | ||
| $44.64M-84.7% | $50.1M-92.9% | $80.54M+53.1% | $146.49M+51.0% | $291.57M+264% | ||
| -$273.15M+46.2% | -$272.67M+71.0% | -$299.6M— | —— | -$507.81M-144% | ||
| $225.59M+149% | -$32.3M-120% | -$320.25M— | $307.04M— | -$455.81M-149% |
FAQ
- How much cash does Royalty Pharma generate?
- Royalty Pharma (RPRX) generated $3.0B in operating cash flow over the trailing twelve months.
- Where does Royalty Pharma's cash flow data come from?
- Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
